Project Grant R01EB038366
- Federal Grant Award Summary The University of Notre Dame DU Lac received a $430,375 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The two-year award, effective August 1, 2025 through July 31, 2027, supports research and development of supramolecular-engineered glucagon-like peptide 1 receptor agonist (GLP-1 RA) depot formulations for...
- Federal Project Grant Award Summary The University of Notre Dame DU Lac received a $622,340 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2025, through May 31, 2027. The award supports research into multispecific bridge nanoparticles designed to engage T cells and off-the-shelf chimeric antigen receptor (CAR)-T cells against antigen-positive endothelial cell (EC) tumors to enhance antitumor immune...
- Federal Grant Award Summary The University of Nevada, Reno received a $150,000 EAGER (Early-Concept Grant for Exploratory Research) award from the National Science Foundation's Division of Civil, Mechanical, and Manufacturing Innovation under the Engineering program (CFDA 47.041), effective August 1, 2025 through July 31, 2027. This collaborative research project develops an innovative Embedded Section-by-Section Bioprinting (ESB) process designed to fabricate large-scale human tissue constructs...
- Federal Project Grant Award Summary The University of Nebraska Medical Center received a $149,826 Early-Concept Grant for Exploratory Research (EAGER) award from the National Science Foundation's Division of Civil, Mechanical, and Manufacturing Innovation under the Engineering program (CFDA 47.041), effective August 1, 2025, through July 31, 2027. The project delivers fundamental research and development services focused on advancing three-dimensional (3D) bioprinting technology for...
- Federal Grant Award Summary The University of Notre Dame DU Lac received a $120,000 Project Grant award dated March 23, 2026, from the Research Development and Engineering Command (Army Materiel Command) under the Basic Scientific Research program (CFDA 12.431). This three-year research initiative, with an ultimate completion date of March 22, 2029, will be conducted at Notre Dame's research facilities in Notre Dame, Indiana. The project focuses on developing atomic-scale insight into the...
- Federal Project Grant Award Summary The University of Notre Dame DU Lac received a $659,122 Project Grant awarded on August 12, 2025, by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct biomedical research on mycobacterial pathogenesis. The research project, which runs through July 31, 2030, focuses on understanding how the ESX-1 secretion system in pathogenic mycobacteria, including Mycobacterium...
- Federal Grant Award Summary The University of Notre Dame received a $599,997 Project Grant award on September 25, 2025, under the Department of the Army's Basic Scientific Research program (CFDA 12.431) to conduct fundamental research on epitaxial altermagnets for spintronics and optical sensing applications. The three-year research initiative, scheduled for completion by September 24, 2028, will be performed at the university's Notre Dame Research division in Notre Dame, Indiana. This award...
- This federal Project Grant award of $250,000 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The funding will support research at the University of Notre Dame DU Lac aimed at "TARGETING NEURAL STEM CELL QUIESCENCE TO PROMOTE REMYELINATION", with a project period from September 1, 2024 to August 31, 2026. The research focuses on developing innovative approaches to address critical medical challenges facing military...
- Federal Grant Award Summary The University of Notre Dame DU Lac received a $459,439 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 7, 2025, with completion scheduled for June 30, 2027. The grant supports research addressing acute cellular rejection (ACR) in organ transplantation through investigation of CD8+ T cell alloreactivity and its relationship to viral...
- Federal Project Grant Award Summary The University of Notre Dame received a $155,204 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on May 27, 2025, with completion targeted for March 31, 2027. The grant funds research titled "Revealing the Structural Determinants of TCR Cross-Recognition via Extended Positional Scanning," conducted at Notre Dame's Research division...
The University of Notre Dame received a $662,737 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective March 5, 2026, with an anticipated completion date of February 28, 2030. The award funds the development of an innovative Hybrid Multi-Material and Multi-Method Autonomous Printing (HM2AP) technology that integrates aerosol jet sacrificial printing with extrusion bioprinting methods to advance three-dimensional tissue engineering capabilities. The project will deliver a paradigm-shifting bioprinting platform capable of constructing complex, hierarchical vascular structures with feature sizes ranging from 10 to 100 micrometers for use in regenerative medicine applications. The technology addresses critical limitations in current sacrificial bioprinting approaches by enabling the fabrication of perfusable blood vessels with higher resolution and greater geometric complexity than previously achievable. The resulting bioprinting system will generate physiologically relevant vascular tissues capable of supporting growth, remodeling, and repair functions, with potential applications in developing functional organ tissues such as vascularized liver constructs for biomedical research and therapeutic use.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $662.7k | 3/2/26 |